Pharmacokinetic and Pharmacodynamic Study of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir after Multiple Oral Dosing

Podobne zapisy

• In Vivo Effect of α(1)-Acid Glycoprotein on Pharmacokinetics of Amprenavir, a Human Immunodeficiency Virus Protease Inhibitor
  od: Sadler, Brian M., i wsp.
  Wydane: (2001)
• Pharmacokinetic Study of Human Immunodeficiency Virus Protease Inhibitors Used in Combination with Amprenavir
  od: Sadler, Brian M., i wsp.
  Wydane: (2001)
• Single-Dose Pharmacokinetics of Amprenavir, a Human Immunodeficiency Virus Type 1 Protease Inhibitor, in Subjects with Normal or Impaired Hepatic Function
  od: Veronese, Laurence, i wsp.
  Wydane: (2000)
• Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor, following Oral Administration of Single Doses to HIV-Infected Adults
  od: Sadler, Brian M., i wsp.
  Wydane: (1999)
• Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice
  od: Demarles, D., i wsp.
  Wydane: (2002)